Lifestyle interventions for four conditions: type 2 diabetes, metabolic syndrome, breast cancer, and prostate cancer
Sumamo E, Ha C, Korownyk C, Vandermeer B, Dryden DM
Record ID 32010001646
English
Authors' objectives:
To synthesize evidence from randomized controlled trials (RCTs) on the effectiveness of lifestyle interventions to control progression of type 2 diabetes, progression to diabetes from metabolic syndrome, or recurrence of breast cancer and prostate cancer. Lifestyle interventions were defined as interventions that included exercise, diet, and at least one other component (e.g., counseling, stress management, smoking cessation).
Authors' recommendations:
Comprehensive lifestyle interventions that include exercise, dietary changes and at least one other component are effective in decreasing the incidence of type 2 diabetes mellitus in high risk patients and the benefit extends beyond the active intervention phase. In patients who have already been diagnosed with type 2 diabetes, there is some evidence to suggest long-term benefit on microvascular and macrovascular outcomes, although the evidence is from one trial of high risk diabetes patients and included pharmacotherapy.The evidence for lifestyle interventions to prevent cancer recurrence is insufficient to draw conclusions.
Comprehensive lifestyle interventions appear to have a positive impact on behavioral outcomes including exercise and dietary intake, as well as a number of metabolic variables, at least in the short-term in all populations addressed in this report.
Details
Project Status:
Completed
URL for project:
https://www.cms.gov/determinationprocess/downloads/id82TA.pdf
Year Published:
2011
URL for published report:
https://www.cms.gov/medicare-coverage-database/details/technology-assessments-details.aspx?TAId=82&bc=AAAQAAAAAAAA&
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
United States
MeSH Terms
- Breast Neoplasms
- Life Style
- Prostatic Neoplasms
Contact
Organisation Name:
Agency for Healthcare Research and Quality
Contact Address:
Center for Outcomes and Evidence Technology Assessment Program, 540 Gaither Road, Rockville, MD 20850, USA. Tel: +1 301 427 1610; Fax: +1 301 427 1639;
Contact Name:
martin.erlichman@ahrq.hhs.gov
Contact Email:
martin.erlichman@ahrq.hhs.gov
Copyright:
Agency for Healthcare Research and Quality (AHRQ)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.